openPR Logo
Press release

Endoscope-Radiofrequency Ablation (RFA) Market Size to Reach US$ 6.67 Billion by 2034 from US$ 4.21 Billion in 2025, Growing at a CAGR of 5.25% (2026-2034)

06-26-2026 01:25 PM CET | Health & Medicine

Press release from: The Insight Partners

Endoscope-Radiofrequency Ablation (RFA) Market

Endoscope-Radiofrequency Ablation (RFA) Market

The Endoscope-Radiofrequency Ablation (RFA) Market Trends are being shaped by rising clinical demand for minimally invasive procedures, growing prevalence of gastrointestinal disorders, and rapid technological advancements in endoscopic systems. According to The Insight Partners, The Endoscope-Radiofrequency Ablation (RFA) Market size is expected to reach US$ 6.67 Billion by 2034 from US$ 4.21 Billion in 2025. The market is estimated to record a CAGR of 5.25% from 2026 to 2034. Increasing awareness among patients and healthcare providers is further accelerating adoption across hospitals and specialty clinics globally.

Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00009783?utm_source=OpenPR&utm_medium=10812

Rising Clinical Demand and Disease Burden Expansion
The increasing incidence of gastrointestinal conditions such as Barrett's esophagus and gastroesophageal reflux disease is a major factor driving procedural uptake. Endoscope-based radiofrequency ablation offers targeted tissue destruction with reduced complications, making it a preferred option compared to conventional surgical interventions. Expanding patient pools across both developed and emerging economies continue to strengthen procedural volumes. Additionally, oncology applications are gaining traction as clinicians explore ablation techniques for tumor management, further broadening clinical usage.

Technological Advancements in Endoscopic Systems
Innovation in endoscopic imaging, catheter-based delivery systems, and precision-controlled energy emission is significantly enhancing treatment outcomes. Modern devices now offer better visualization and improved targeting accuracy, reducing procedural risks. Integration of hybrid techniques combining ablation with other minimally invasive approaches is also expanding treatment possibilities. These advancements are enabling clinicians to address complex conditions more effectively, thereby supporting broader adoption across specialized healthcare settings.

Application Diversification Across Therapeutic Areas
Originally concentrated in gastroenterology, endoscope-radiofrequency ablation is now expanding into multiple therapeutic areas. Cardiology applications are evolving in rhythm management procedures, while pain management uses continue to grow due to improved nerve ablation outcomes. Oncology remains a key growth segment, particularly for tumor reduction therapies. This diversification is enhancing procedural versatility and opening new clinical pathways, contributing to sustained long-term demand.

Read For More Information: - https://www.theinsightpartners.com/reports/endoscope-radiofrequency-ablation-rfa-market

Regional Expansion and Healthcare Infrastructure Development
North America continues to dominate due to advanced healthcare infrastructure, high disease awareness, and strong adoption of innovative technologies. Europe follows closely, supported by robust clinical research and regulatory support for minimally invasive procedures.

Asia Pacific is emerging as a high-growth region driven by increasing healthcare investments, expanding hospital networks, and rising patient awareness. Countries such as China and India are witnessing rapid adoption due to large patient populations and improving access to advanced medical technologies.

Competitive Landscape and Strategic Developments
The competitive environment is characterized by continuous innovation, strategic collaborations, and product expansion initiatives. Key companies are investing heavily in research and development to improve device safety and efficacy. Strategic partnerships with healthcare providers and training institutions are also helping expand procedural adoption globally.

Key players include:
• AngioDynamics, Inc.
• Arthrex, Inc.
• AtriCure, Inc.
• Boston Scientific Corporation
• Medtronic Plc.
• Stryker Corporation
• Smith & Nephew Plc.

These organizations are focusing on next-generation ablation platforms, enhanced training programs, and geographic expansion strategies to strengthen their global footprint.

Interested in Purchasing this Report? Click here @
https://www.theinsightpartners.com/buy/TIPRE00009783?utm_source=OpenPR&utm_medium=10812

Future Outlook
The Endoscope-Radiofrequency Ablation (RFA) sector is expected to witness steady growth through 2034, supported by continued technological innovation and expanding clinical applications. Increasing integration of hybrid therapeutic techniques, combined with rising demand for patient-centric minimally invasive treatments, will further enhance adoption.

Related Report:
1) Brachytherapy Devices Market - https://www.theinsightpartners.com/reports/brachy-therapy-devices-market

2) Spinal Cord Stimulation Devices Market - https://www.theinsightpartners.com/reports/spinal-cord-stimulation-devices-market

3) Embolization Plugs Market - https://www.theinsightpartners.com/reports/embolization-plugs-market

Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endoscope-Radiofrequency Ablation (RFA) Market Size to Reach US$ 6.67 Billion by 2034 from US$ 4.21 Billion in 2025, Growing at a CAGR of 5.25% (2026-2034) here

News-ID: 4561895 • Views:

More Releases from The Insight Partners

Samarium Market Demand, Share & Growth by 2034
Samarium Market Demand, Share & Growth by 2034
Samarium is a rare earth element widely used in advanced industrial and technological applications. It belongs to the lanthanide series and is known for its magnetic, optical, and catalytic properties. Samarium plays a critical role in the production of high performance magnets, nuclear reactors, electronics components, and specialized alloys. To Get Sample Copy of Report, Click Here - https://www.theinsightpartners.com/sample/TIPRE00003588/?utm_source=OpenPR&utm_medium=10607 Samarium Market Analysis The growing demand for efficient electronic systems,
Heart Defect Closure Device Market Size to Reach US$ 12.07 Billion by 2034 from US$ 3.03 Billion in 2025, Growing at a CAGR of 16.6% (2026-2034)
Heart Defect Closure Device Market Size to Reach US$ 12.07 Billion by 2034 from …
The Heart Defect Closure Device Market Growth is strongly influenced by expanding indications for transcatheter closure procedures and technological innovation across device types. According to The Insight Partners, Valued at US$ 3.03 Billion in 2025, the industry is projected to reach US$ 12.07 Billion by 2034, registering a CAGR of 16.6% during the forecast period 2026-2034. Increasing adoption across atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus
Global Ethanol Market to Surpass US$ 118.77 Billion by 2034 as Renewable Fuel Demand and Government Policies Drive Growth
Global Ethanol Market to Surpass US$ 118.77 Billion by 2034 as Renewable Fuel De …
The Global Ethanol Market is experiencing steady growth as industries and governments worldwide continue to prioritize renewable energy, cleaner transportation fuels, and sustainable industrial applications. Ethanol, a renewable alcohol produced primarily from sugarcane, corn, wheat, barley, and other biomass feedstocks, has become an essential component in fuel blending, industrial solvents, beverages, disinfectants, and personal care products. The increasing emphasis on reducing greenhouse gas emissions and enhancing energy security is significantly
Baking Ingredients Market Worth US$22.28 Billion by 2028, Growing from US$16.44 Billion in 2022
Baking Ingredients Market Worth US$22.28 Billion by 2028, Growing from US$16.44 …
The global Baking Ingredients Market continues to evolve as consumer preferences shift toward healthier, premium-quality, and clean-label bakery products. Baking ingredients including emulsifiers, enzymes, leavening agents, starches, flavors, colors, preservatives, oils, fats, and specialty blends-play a vital role in enhancing texture, taste, shelf life, and nutritional value across a wide range of bakery applications. Growing demand for artisan bakery products, convenience foods, frozen bakery items, and functional baked goods is creating

All 5 Releases


More Releases for Ablation

Pulsed Field Ablation Market Analysis on Therapeutic Area Product Components and …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pulsed Field Ablation Market- (By Therapeutic Area (Cardiovascular Disorders, Oncological Disorders, Respiratory Disorders, Dermatological Disorders), By Product Components (Catheter, Generator, By Application Area (Ablation, Ablation and Mapping), By Source of Ablation (Pulsed Field Energy, Pulsed Field and Radiofrequency Energy, Pulsed Field and Cryoablation Energy)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the
Thyroid Ablation Devices Market
Alarming rise in prevalence of thyroid cancer, advancements in thyroid ablation system, rise in government & private funds for development of healthcare sectors, and increase in number of thyroid nodule cases are expected to notably contribute toward the growth of the global thyroid ablation devices market during the forecast period. Rise in prevalence of thyroid cancer and thyroid nodules, demand for minimally invasive procedures, and technological advancements in ablation devices drive
03-12-2021 | Health & Medicine
Fact.MR
Atrial Fibrillation (AF) Ablation Market by Procedure (Catheter Ablation, Surgic …
Arterial fibrillation is a disease that creates irregular and rapid heart rate. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very fast rate, out of coordination with the lower ventricles of the heart due to which the time decreases for the heart muscle relaxation. This increases the rate of heart failure and heart strokes and reduces
Radiofrequency Ablation Devices Market: Emerging Applications of Radiofrequency …
Radiofrequency ablation is a minimally invasive technique that uses heat and electrical energy to destroy cancer cells and other dysfunctional tissues. Recently, it has been used to treat a wide range of medical conditions. Although it is not a primary treatment of cancer, it is used to treat a spot of tumor causing pain and other medical indications. The technique is also used to treat patients suffering from adrenal gland,
Nerve Ablation Devices Market to Record an Exponential CAGR by 2028(Based on pro …
Nerves are the vital part of the body, responsible for carrying signals from different parts of the body to the brain. The nerves carry electrical signals that act on actions such as pain and other movements of the body. The nerve ablation devices are used to treat patient by minimally invasive procedures, where a microelectrode is inserted inside the patient to heat the nerve tissue. The nerve ablation devices help
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat